Cargando…

PCOS: A Chronic Disease That Fails to Produce Adequately Specialized Pro-Resolving Lipid Mediators (SPMs)

Introduction: Polycystic ovary syndrome (PCOS) is an endocrinological disorder that affects 5–15% of women of their reproductive age and is a frequent cause of infertility. Major symptoms include hyperandrogenism, ovulatory dysfunction, and often obesity and/or insulin resistance. PCOS also represen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Regidor, Pedro-Antonio, de la Rosa, Xavier, Müller, Anna, Mayr, Manuela, Gonzalez Santos, Fernando, Gracia Banzo, Rafael, Rizo, Jose Miguel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962413/ https://www.ncbi.nlm.nih.gov/pubmed/35203665 http://dx.doi.org/10.3390/biomedicines10020456

Ejemplares similares

Chronic Inflammation in PCOS: The Potential Benefits of Specialized Pro-Resolving Lipid Mediators (SPMs) in the Improvement of the Resolutive Response
por: Regidor, Pedro-Antonio, et al.
Publicado: (2020)

Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2012)

E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition
por: Serhan, Charles N., et al.
Publicado: (2022)

Immunomodulation of periodontitis with SPMs
por: Sahni, Vaibhav, et al.
Publicado: (2023)

Pro resolving inflammatory effects of the lipid mediators of omega 3 fatty acids and its implication in SARS COVID-19
por: Regidor, Pedro-Antonio, et al.
Publicado: (2020)

A Deeper Assessment of ω3-Poly-Unsaturated Fatty Acids in Polycystic Ovary Syndrome Management. Comment on Regidor et al. Chronic Inflammation in PCOS: The Potential Benefits of Specialized Pro-Resolving Lipid Mediators (SPMs) in the Improvement of the Resolutive Response. Int. J. Mol. Sci. 2021, 22, 384
por: Unfer, Vittorio
Publicado: (2021)

Set-level threshold-free tests on the intrinsic volumes of SPMs
por: Barnes, Gareth R., et al.
Publicado: (2013)

Specialized Pro-Resolving Lipid Mediators in Cystic Fibrosis
por: Philippe, Réginald, et al.
Publicado: (2018)

Comparison of Disease Activity in SPMS and PPMS in the Context of Multicenter Clinical Trials
por: Orbach, Rotem, et al.
Publicado: (2012)

Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2020)

Specialized Pro-resolving Lipid Mediators and Resolution of Viral Diseases
por: Ferri, Giulia, et al.
Publicado: (2023)

Fecal microbiota transplantation associated with 10 years of stability in a patient with SPMS
por: Makkawi, Seraj, et al.
Publicado: (2018)

N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer’s disease
por: Lee, Ju Youn, et al.
Publicado: (2020)

Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?
por: Chávez-Castillo, Mervin, et al.
Publicado: (2021)

Specialized pro-resolving lipid mediators in endodontics: a narrative review
por: Aubeux, Davy, et al.
Publicado: (2021)

Specialized Pro-Resolving Lipid Mediators in Neonatal Cardiovascular Physiology and Diseases
por: Gila-Diaz, Andrea, et al.
Publicado: (2021)

The Role of Specialized Pro-Resolving Lipid Mediators in Inflammation-Induced Carcinogenesis
por: Torres, Wheeler, et al.
Publicado: (2023)

Specialized Pro-Resolving Mediators and the Lymphatic System
por: Kraft, Jamie D., et al.
Publicado: (2021)

Roles of Specialized Pro-Resolving Lipid Mediators in Cerebral Ischemia Reperfusion Injury
por: Yin, Ping, et al.
Publicado: (2018)

Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling
por: Díaz del Campo, Lucía Serrano, et al.
Publicado: (2022)

Specialized Pro-Resolving Lipid Mediators: Endogenous Roles and Pharmacological Activities in Infections
por: Rasquel-Oliveira, Fernanda S., et al.
Publicado: (2023)

Role of Specialized Pro-Resolving Mediators in Neuropathic Pain
por: Leuti, Alessandro, et al.
Publicado: (2021)

An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques
por: Fredman, Gabrielle, et al.
Publicado: (2016)

Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development
por: Yang, Ailin, et al.
Publicado: (2021)

Sex differences in specialized pro-resolving lipid mediators and their receptors in abdominal aortic aneurysms
por: Filiberto, Amanda C., et al.
Publicado: (2023)

Specialized pro-resolving mediators: endogenous regulators of infection and inflammation
por: Basil, Maria C., et al.
Publicado: (2015)

The Role of Sphingolipids and Specialized Pro-Resolving Mediators in Alzheimer’s Disease
por: de Wit, Nienke M., et al.
Publicado: (2021)

The Use of Specialized Pro-Resolving Mediators in Biomaterial-Based Immunomodulation
por: Sousa, Ana Beatriz, et al.
Publicado: (2023)

Lipids in Liver Failure Syndromes: A Focus on Eicosanoids, Specialized Pro-Resolving Lipid Mediators and Lysophospholipids
por: Artru, Florent, et al.
Publicado: (2022)

Early increase of specialized pro-resolving lipid mediators in patients with ST-elevation myocardial infarction
por: Fosshaug, Linn E., et al.
Publicado: (2019)

Subgingival Microbiome and Specialized Pro-Resolving Lipid Mediator Pathway Profiles Are Correlated in Periodontal Inflammation
por: Lee, Chun-Teh, et al.
Publicado: (2021)

Specialized Pro-resolving Lipid Mediators and Glial Cells: Emerging Candidates for Brain Homeostasis and Repair
por: Tiberi, Marta, et al.
Publicado: (2021)

Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?
por: Schebb, Nils Helge, et al.
Publicado: (2022)

Current experimental methods to investigate the impact of specialized pro-resolving lipid mediators on Sjögren’s syndrome
por: dos Santos, Harim T., et al.
Publicado: (2023)

The Role of Specialized Pro-Resolving Mediators in Cystic Fibrosis Airways Disease
por: Briottet, Maelle, et al.
Publicado: (2020)

Role of Specialized Pro-resolving Mediators in Reducing Neuroinflammation in Neurodegenerative Disorders
por: Ponce, Jana, et al.
Publicado: (2022)

Utility of the Specialized Pro-Resolving Mediators as Diagnostic and Prognostic Biomarkers in Disease
por: Dalli, Jesmond, et al.
Publicado: (2022)

Critical Role of Inflammation and Specialized Pro-Resolving Mediators in the Pathogenesis of Atherosclerosis
por: Rangarajan, Subhapradha, et al.
Publicado: (2022)

Pharmacokinetics and Changes in Lipid Mediator Profiling after Consumption of Specialized Pro-Resolving Lipid-Mediator-Enriched Marine Oil in Healthy Subjects
por: Irún, Pilar, et al.
Publicado: (2023)

Soluble Mediators Produced by Pro-Resolving Macrophages Inhibit Angiogenesis
por: Michaeli, Shira, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_iqlufvefcrg6spne12a3i3d8db